ascopubs.org

Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy ...

Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols ...
Science Daily

Long-term benefit of SABR for operable early-stage NSCLC shown in new study

A new study showed that stereotactic ablative radiotherapy (SABR) was as effective as surgery at providing long-term benefits to patients with operable early-stage non-small cell lung cancer (NSCLC) ...
Science Daily

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

"Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer." ScienceDaily. www.sciencedaily.com / releases / 2024 / 05 / 240515224836.htm (accessed April 18, 2026).
ascopubs.org

A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403)—Long term follow-up results.

Long-term survival comparison of stereotactic radiotherapy versus surgery for elderly patients with clinical stage T1-T2 non-small cell lung cancer. Effect of radiation dose escalation on outcomes in ...
Nature

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate

The goal of chemotherapy given in the adjuvant or neoadjuvant (preoperative) setting is to eradicate occult distant metastases and to increase ultimately the probability of disease-free survival (Bear ...